Transforming PCI Informed Consent Into an Evidence-based Decision-making Tool
NCT01383382 is an observational study sponsored by Saint Luke's Health System. As of 21 Nov 2026, it is completed. It studies Non-emergent Percutaneous Coronary Intervention (PCI). The registry lists an enrollment of 1,399 participants at 7 sites in 1 country. The registry lists a start date of 30 Sept 2009 and a primary completion date of 31 Oct 2011. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01383382 |
| Status | Completed |
| Study type | Observational study |
| Lead sponsor | Saint Luke's Health System |
| Enrollment | 1,399 |
| Registered sites | 7 |
| Countries | 1 |
| Conditions | Non-emergent Percutaneous Coronary Intervention (PCI) |
| Start | 30 Sept 2009 |
| Primary completion | 31 Oct 2011 |
| Study completion | 30 Sept 2012 |
| Last update posted | 10 Sept 2012 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- John A Spertus, MD, MPH
St. Luke's Hospital, Kansas City, Missouri
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kaiser Permanente
Oakland
- Prairie Education and Research Cooperative
Springfield
- Baystate Medical Center
Springfield
- Henry Ford Health System
Detroit
- Saint Luke's Hospital of Kansas City
Kansas City
- Barnes-Jewish Hospital/washington University School of Medicine
St Louis
- Baylor Research Institute
Plano
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT01383382
Each answer restates registry values shown on this page.
What is NCT01383382?
NCT01383382 is an observational study sponsored by Saint Luke's Health System. It studies Non-emergent Percutaneous Coronary Intervention (PCI).
Who leads NCT01383382?
The registry names John A Spertus, MD, MPH (principal investigator, St. Luke's Hospital, Kansas City, Missouri) as the overall official.
Where does NCT01383382 run?
The registry lists 7 sites in 1 country. Every site with a stated country is in one country: United States.
When did NCT01383382 end?
The registry lists a primary completion date of 31 Oct 2011 and a study completion date of 30 Sept 2012. The sponsor last updated the record on 10 Sept 2012.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.